Form 4 for LLY Lilly (Eli)
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0000059478-22-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | LLY | Hakim Anat | SVP, GC, Sec | M - OptEx | $0.00 | +7,929 | 12.4K | +179% | $0 |
| D | 2022-03-03 | 2022-03-01 | LLY | Hakim Anat | SVP, GC, Sec | F - Tax | $249.95 | -3,500 | 8,864 | -28% | -$874.8K |
| D | 2022-03-03 | 2022-03-01 | LLY | Hakim Anat | SVP, GC, Sec | M - OptEx | $0.00 | -7,929 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | M | A | 7,929 | $0.00 | 12,364 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | F | D | 3,500 | $249.95 | 8,864 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-03-01 | M | D | 7,929 | $0.00 | 0 | D | — · — to — | 7,929 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. (F2) The restricted stock units vested on March 1, 2022. |